AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ELECO PUBLIC LIMITED COMPANY

Share Issue/Capital Change Jan 6, 2020

7618_rns_2020-01-06_cbf3af49-5c57-4207-aab2-7fa7dae802c1.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8823Y

UDG Healthcare Public Limited Co.

06 January 2020

BLOCK LISTING SIX MONTHLY RETURN

Date: 6 January 2020

Name of applicant: UDG HEALTHCARE PLC
Name of scheme: UNITED DRUG PLC EXECUTIVE SHARE OPTION PLAN
Period of return: From: 1 July 2019 To: 31 December 2019
Balance of unallotted securities under scheme(s) from previous return: 370,727
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 37,800
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 332,927
Name of contact: Damien Moynagh
Telephone number of contact: + 353 1 468 9000

BLOCK LISTING SIX MONTHLY RETURN

Date: 6 January 2020

Name of applicant: UDG HEALTHCARE PLC
Name of scheme: UNITED DRUG PLC LONG TERM INCENTIVE PLAN
Period of return: From: 1 July 2019 To: 31 December 2019
Balance of unallotted securities under scheme(s) from previous return: 3,139,482
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 279,640
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 2,859,842
Name of contact: Damien Moynagh
Telephone number of contact: + 353 1 468 9000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRBXGDBLBGDGGL

Talk to a Data Expert

Have a question? We'll get back to you promptly.